|
Yale Cancer Center NCTN
|
3U10CA180826-03S1
|
$49,901
|
$2,495
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-04
|
$951,500
|
$47,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Vitamin D and Colorectal Cancer
|
1R01CA122299-01A2
|
$360,095
|
|
BENYA, RICHARD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Viral and cellular gene regulation during lytic KSHV replication
|
5R01CA119905-03
|
$223,497
|
|
Swaminathan, Sankar
|
UNIVERSITY OF FLORIDA
|
|
Vasculogenesis in Ewing's Sarcoma: Implications for Therapy
|
2R01CA103986-04A1
|
$254,023
|
|
Kleinerman, Eugenie
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Variation in Ara-C Pathway Genes and Treatment Outcomes in AML
|
5R21CA119142-02
|
$152,926
|
|
GOYAL, RAKESH
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$1,250
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$318
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$42,885
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
|
5R01CA102646-04
|
$311,617
|
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
University of Virginia Cancer Center Support Grant
|
2P30CA044579-26
|
$2,574,504
|
$51,490
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-26S1
|
$125,000
|
$2,500
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-26S2
|
$104,087
|
$2,082
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S3
|
$6,166,044
|
$123,321
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S4
|
$50,000
|
$1,000
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S5
|
$30,973
|
$619
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Colorado Cancer Center Support Grant
|
2P30CA046934-29
|
$3,880,607
|
$77,612
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-29S1
|
$3,780
|
$76
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-29S2
|
$104,106
|
$2,082
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Univ. of Guam/Cancer Res. Center of Hawaii Partnership
|
3U56CA096254-05S1
|
$100,000
|
|
VOGEL, CARL-WILHELM
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Univ of Guam/Cancer Res Center of Hawaii Partnership
|
3U56CA096278-05S1
|
$37,340
|
|
Whippy, Helen
|
UNIVERSITY OF GUAM
|
|
Understanding Reversed Race/Ethnic Associations with Cancer Screening Tests
|
5R21CA127828-02
|
$191,838
|
|
RAKOWSKI, WILLIAM
|
BROWN UNIVERSITY
|
|
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
|
5R01CA118085-03
|
$290,571
|
|
ZHOU, PENGBO
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
TXNIP as a Key Regulator of Thyroid Cancer Metabolism and Aggressiveness
|
5R01CA175994-05
|
$322,663
|
$322,663
|
HAUGEN, BRYAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Two Delivery Channels to Improve CRC Screening
|
5R01CA102695-04
|
$453,574
|
|
WEINBERG, DAVID
|
FOX CHASE CANCER CENTER
|
|
Tumor and PTK-Targeted Therapy by FUS1 and PTK inhibitor
|
5R01CA116322-02
|
$292,600
|
|
JI, LIN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Trinity Field Study
|
ZIA CP010185-10694
|
$235,630
|
$141,378
|
Simon, Steven
|
DCEG (NCI)
|
|
Treatment decision making in low-risk thyroid cancer
|
5R01CA201198-02
|
$759,437
|
$759,437
|
HAYMART, MEGAN
|
UNIVERSITY OF MICHIGAN
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$192,132
|
$5,764
|
Merino, Maria
|
CCR (NCI)
|
|
Translational Investigation of KRas & NF1 in Myeloid Leukemia
|
5R37CA072614-12
|
$309,845
|
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Tracking Symptoms during Chemotherapy via Online Patient Self-reporting
|
1K07CA124851-01A1
|
$133,978
|
|
Basch, Ethan
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Tissue Specific Gene Therapy for Human Prostate Cancer
|
5R01CA074042-11
|
$265,033
|
|
Kao, Chinghai
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Tissue Array Research Program
|
Z01 BC 010923
|
$561,297
|
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Timing of dietary exposure and breast cancer risk
|
3U54CA100970-05S1
|
|
|
HILAKIVI-CLARKE, LEENA
|
GEORGETOWN UNIVERSITY
|
|
Thyroid Cancer among Chornobyl Clean-up Workers in Ukraine: Pilot Study
|
ZIA CP010133-10531
|
$137,961
|
$137,961
|
Mabuchi, Kiyohiko
|
DCEG (NCI)
|
|
Therapeutic targets and novel anticancer agents for endocrine cancers
|
ZIA BC 011286
|
$747,451
|
$373,726
|
Kebebew, Electron
|
CCR (NCI)
|
|
Theranostic nanoparticles for the treatment of RAI refractory thyroid cancer
|
5R01CA178007-05
|
$351,713
|
$351,713
|
JIN, MOONSOO
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
The Role of Selenium in Intestinal Inflammation and Cancer
|
5R21CA123334-02
|
$199,200
|
|
Jelicks, Linda
|
YESHIVA UNIVERSITY
|
|
The role of glutathione peroxidase in the pathogenesis of intestinal cancer
|
5R01CA114569-03
|
$262,148
|
|
Chu, Fong-Fong
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
The Role of Fragile Sites in RET/PTC Rearrangement
|
5R01CA113863-08
|
$299,136
|
$299,136
|
WANG, YUH-HWA
|
UNIVERSITY OF VIRGINIA
|
|
The Role of Behavioral Science in Personalized Genetic Medicine
|
1K07CA131172-01
|
$136,778
|
|
GRAVES, KRISTI
|
GEORGETOWN UNIVERSITY
|
|
The Role of BCR/ABL in Regulating DNA Repair
|
5R01CA100885-05
|
$246,470
|
|
CARROLL, MARTIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Protective Effects of Physical Activity on AdolescentSmoking Progression
|
1R01CA126958-01A1
|
$633,807
|
|
AUDRAIN-MCGOVERN, JANET
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE
|
5P50CA168505-05
|
$2,278,318
|
$2,278,318
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
|
The Chernobyl Tissue Bank - Coordinating Center
|
2U24CA082102-17
|
$324,000
|
$324,000
|
THOMAS, GERALDINE
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
|
TGIB Surgical Oncology Fellowship Program
|
ZIE BC 011542
|
$972,309
|
$48,615
|
Schrump, David
|
CCR (NCI)
|
|
TERT Promoter Mutations in Thyroid Cancer
|
5R01CA189224-03
|
$367,455
|
$367,455
|
XING, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Telephone and Web-based Teen Tobacco Cessation in HMOs
|
5R01CA098685-05
|
$408,463
|
|
HOLLIS, JACK
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
TCR Diagnostics in LGL Leukemia and Immune Cytopenias
|
5R01CA113972-04
|
$286,517
|
|
Maciejewski, Jaroslaw
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Targeting the Tumor Vasculature to Treat Cancer
|
Z01 SC 010368
|
$975,628
|
$292,689
|
Libutti, Steven
|
CCR (NCI)
|
Total relevant funding to Thyroid for this search: $25,347,809
|